Cynthia Phelan1, Eric Wooltorton. Show Affiliations » 1. Department of Family Medicine, University of Ottawa.
Abstract
Mesh: See more » Antibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useArthritis, Rheumatoid/diagnosisArthritis, Rheumatoid/drug therapyBlood Chemical AnalysisCanadaCrohn Disease/diagnosisCrohn Disease/drug therapyFemaleHematologic Diseases/chemically inducedHematologic Diseases/epidemiologyHumansIncidenceInfliximabMaleMonitoring, PhysiologicRisk AssessmentSeverity of Illness IndexTumor Necrosis Factor-alpha/antagonists & inhibitorsUnited StatesUnited States Food and Drug Administration
Substances: See more » Antibodies, MonoclonalTumor Necrosis Factor-alphaInfliximab
Year: 2004 PMID: 15505264 PMCID: PMC526325 DOI: 10.1503/cmaj.1041597
Source DB: PubMed Journal: CMAJ ISSN: 0820-3946 Impact factor: 8.262